02.19.20

Ribomic Announces First Injection in the Phase 2 Clinical Trial of RBM-007 (TOFU Study) in Subjects with Wet AMD

Source: Ribomic

02.13.20

Not All With AMD May Need Continuing Treatment

Source: Reuters

02.10.20

Adverum Reports New Interim Data from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

Source: Adverum Biotechnologies

02.10.20

Kodiak Sciences Announces Additional Data from Ongoing Phase 1b Study of KSI-301 in Patients With Retinal Diseases

Source: Kodiak Sciences

01.23.20

Treat-and-Extend Approach With Ranibizumab Effective in AMD

Source: Reuters Health

01.13.20

Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases

Source: Exonate

12.27.19

Novartis Receives Permanent J-code for Beovu

Source: Novartis

12.16.19

Novartis Receives Positive CHMP Opinion for Beovu (Brolucizumab) for the Treatment of Wet AMD

Source: Novartis

10.30.19

Regenxbio Exercises Option for Global License for Use of SCS Microinjector in AAV Gene Therapy Delivery

Source: Clearside Biomedical

10.24.19

Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Clinical Trial of Intravitreal Gene Therapy for Wet AMD

Source: Adverum Biotechnologies

View more stories